Section I Basic Science and Practical Issues 1 Radiofarmaceutical Compounds
2 Method and Preparation of the Patient
3 18F-FDG Administration and Dosimetry
4 Physiological Pattern and Pitfall of 18F-FDG Biodistribution
Section II Oncology 5 Malignant Lymphoma in Children
6 18-FDG PET/CT in Pediatric Lymphoma
7 Other Haematological Diseases (Leukemia)
8 Primary Bone Tumors
9 Utility of 18F-FDG PET/CT in Soft Tissue Sarcomas
10 Primary Hepatic Tumors
11 Neuroendocrine Tumors
12 Neuroblastoma
Other Tumors 13 Pediatric Nasopharyngeal Carcinoma
14 Poorly Differentiated Thyroid Carcinoma
15 Phylloid Tumor of the Breast
16 Wilms Tumor
17 Adrenal Gland Cancer
18 Ovarian Teratoma
Section III Neurology 19 Role of Aminoacid PET Tracers in Pediatric Brain Tumors
20 18F-FDG in Brain Tumors
21 PET/CT in the Clinical Evaluation of Pediatric Epilepsy
22 Epilepsia Partialis Continua
23 Brain 18F- FDG PET/CT Imaging in Haemolytic Uraemic Syndrome (HUS) During and After the Acute Phase
Section IV Infection and Inflammation 24 Inflammatory Bowel Disease
25 Appendicitis
26 Spondylodiscitis
27 Other Bone Lesion
28 Pulmonary Aspergillosis
29 Mycobatteriosis
Section V Other Applications 30 Sarcoidosis
31 Neurofibromatosis
32 Autoimmune Lymphoproliferative Syndrome (ALPS). 33 Castelman's Disease
34 Fever of Unknown Origin
35 Congenital Hyperinsulinism
36 Myocardial Perfusion Imaging with Rb Cardiac PET/CT.